Drug Screening Market
According to Intent Market Research, the Drug Screening Market is expected to grow from USD 7.3 billion in 2023 at a CAGR of 10.2% to touch USD 14.4 billion by 2030. The Drug Screening Market is dominated by key players such as Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Quest Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Dr–gerwerk AG & Co. KGaA, PerkinElmer, Alere Inc. (now part of Abbott), BD (Becton, Dickinson and Company), Randox Laboratories, Merck Group and Creative Diagnostics.